New Zealand markets closed

Sonoma Pharmaceuticals, Inc. (SNOA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.2100-0.1600 (-4.75%)
At close: 04:00PM EDT
3.5200 +0.31 (+9.66%)
After hours: 07:16PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 10.38M
Enterprise value 4.35M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.70
Price/book (mrq)1.19
Enterprise value/revenue 0.34
Enterprise value/EBITDA -0.76

Trading information

Stock price history

Beta (5Y monthly) 0.97
52-week change 3-45.22%
S&P500 52-week change 3-7.20%
52-week high 313.3600
52-week low 32.5500
50-day moving average 33.1150
200-day moving average 33.8189

Share statistics

Avg vol (3-month) 390.66k
Avg vol (10-day) 3192.76k
Shares outstanding 53.1M
Implied shares outstanding 6N/A
Float 83.08M
% held by insiders 10.39%
% held by institutions 15.55%
Shares short (14 Jul 2022) 421.05k
Short ratio (14 Jul 2022) 41.39
Short % of float (14 Jul 2022) 40.68%
Short % of shares outstanding (14 Jul 2022) 40.68%
Shares short (prior month 14 Jun 2022) 436.46k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 319 Jun 2019
Ex-dividend date 4N/A
Last split factor 21:9
Last split date 319 Jun 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Mar 2022
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin -40.28%
Operating margin (ttm)-46.62%

Management effectiveness

Return on assets (ttm)-21.75%
Return on equity (ttm)-72.35%

Income statement

Revenue (ttm)12.63M
Revenue per share (ttm)4.76
Quarterly revenue growth (yoy)6.50%
Gross profit (ttm)3.99M
EBITDA -5.7M
Net income avi to common (ttm)-5.09M
Diluted EPS (ttm)-2.4160
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.4M
Total cash per share (mrq)2.38
Total debt (mrq)1.37M
Total debt/equity (mrq)15.72
Current ratio (mrq)2.82
Book value per share (mrq)2.81

Cash flow statement

Operating cash flow (ttm)-4.25M
Levered free cash flow (ttm)-2.01M